the use of topical tranexamic acid in total hip arthroplasty

Phase 2

• Conditions: Multiple injuries of hip and thigh; Patients candidate for total hip arthroplasty.

• Registration Number: IRCT201509056280N8
• Lead Sponsor: Vice Chancellaor foe Research of Guilan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

patients who undergoing total hip arthroplasty surgery; 50-20 years old; ASA (American Society of Anesthesia) I-II; having HB= 10gr dl before surgery ; not receiving transfusion before surgery.

The exclusion criteria:
Emergency surgery; Hb<10mg/dl; The evidence for any condition of IHD or treatment; The evidence for hemorrhagic CVA ; SAH OR STROK; The evidence for TBI; Use of anticoagulant drug; any history of renal ; liver and anemia before operation; History of OCP consumption.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intraoperative and postoperative hemorrhage. Timepoint: after operation and 24 hours after that. Method of measurement: based on blod on suction and gauze counting and gilcher formula.

Secondary Outcome Measures

Name	Time	Method
Packed cell. Timepoint: intraoperative and 24 hours after surgery. Method of measurement: number of packed cell.